Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that the Company has begun a Phase II study using a topically applied spray formulation of AVR 118 as a wound healing agent. Based upon the preliminary results previously seen in an animal model at the University of Miami, this study is designed to determine if a similar response can be demonstrated in humans. The study population will be divided into two cohorts of patients who will undergo a one week course of therapy.

The first cohort of patients will have undergone plastic surgery and must present a minimum of two bilateral surgical wounds. AVR118 will be applied to one wound so that the second wound will serve as an untreated control. The objective is to determine if AVR 118 can accelerate the time taken for the wound to close.

What comes after the Armchair Auction

You've bid on an item in the Alabama Shakespeare Festival's annual Armchair Auction -- now what? Here's what comes next:

Please call the number provided and arrange pickup (be sure to bring along your receipt). If you choose to have your item shipped to you, you will be responsible for shipping expenses. As a courtesy to donors, ASF asks that high bidders make arrangements to pickup items as soon as possible.

CollaGenex Pharmaceuticals to Present at the Wachovia Securities 2007 Healthcare Conference

CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will present at the Wachovia Securities 2007 Healthcare Conference. The presentation is scheduled to begin at 2:00 p.m. EST on Tuesday, January 30, 2007, at the Langham Hotel in Boston, MA.

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on developing and marketing innovative proprietary medical therapies to the dermatology market.

eFoodSafety.com, Inc. Announces Addition of Internet Retailers CVS ...

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that CVS.com, Amazon.com, and drugstore.com are now carrying Cinnergen™, the Company's all natural, liquid nutritional supplement designed to regulate blood sugar.

Amazon.com (NASDAQ:AMZN), www.amazon.com, a Fortune 500 company based in Seattle, opened its virtual doors on the World Wide Web in July 1995 and today offers Earth's biggest selection.